A Research Study On Cancer Essay

Any adverse event for which the specificity or severity is not consistent with the protocol-related documents, including the applicable investigator brochure, IRB approved consent form, Investigational New Drug (IND) or Investigational

As the cells change, it begins to divide rapidly causing a tumor to form. The term “breast cancer” refers to a malignant tumor that has developed from cells in the breast. Breast cancer can begin in different areas of the breast, or in some cases, the tissues in between. There are many different types of breast cancer, including non-invasive, invasive, recurrent, metastatic breast cancer, as well as the intrinsic or molecular subtypes of breast cancer. Human epidermal growth factor receptor 2 (HER2) is overexpressed in around 20-30% of breast cancer tumors. It is associated with a more aggressive disease, higher recurrence rate, and increased mortality.

The aim of this essay is to evaluate the implications of the recent government health initiative ‘Be Clear on Cancer’. Here, a brief history of why the initiative was introduced in relation to public health and the political agenda will be discussed. However, it is first essential to understand how the modern healthcare has been shaped by historic and recent developments. Furthermore, understanding the influence on healthcare practice of healthcare theories and various models will be investigated in this essay. Again, it is vital to critically relate the healthcare practice to the healthcare theories in accordance with the literature review.

It is no secret that cancer is leading cause of death in the world. It was estimated that in 2012, 14.1 million new cases of cancer occurred worldwide and 8.2 million people died as a result of cancer [1]. Cancer prevalence is increasing at an alarming rate, yet the progress of treatment has been slow, with benefits of treatment being measured in only months or even weeks. Most patients with a specific type of cancer at a certain stage will receive the exact same form of treatment, but it has been made clear that while the treatment works well for some, it does not for a significant amount of others. The treatment that patients receive today is based on

Surgery. Radiation. Chemotherapy. Repeat. The treatments that are supposed to cure you bring you closer to the brink of death than you have ever been before. At the final stages, many people pray for death to relieve their suffering. This high tech form of torture should not be how it ends anyone. I watched my 79-year-old grandmother endure these treatments over the course of six months as she slowly slipped into the abyss that is death. By the end, she was no longer the same grandmother that would wake up early whenever we slept over to make us milkshakes and pancakes for breakfast, no longer the same grandmother that seemed to know everything there was to know. This is what people go through every day. Individuals, families, loved ones, they

Cancer. We all know someone who has suffered from it or has passed away because of it. Cancer now affects one in every three people, and is the second highest cause of death in the United States. For decades, the medical community has been on the hunt for a cure for cancer, and have been subjected to intense ridicule from the public because of a lack of progression toward a possible cure. In recent years, many scientists, doctors, researchers, and the general public have come to believe that the cure for cancer is being suppressed because of this lack of progress. Those who say it is suppressed claim that the drugs used to treat cancer actually cause cancer, making a patient sicker and sicker. As a result, the patients are forced to spend

The lack of chemotherapy drugs can present an enormous impact on healthcare. According to McKeever, Bloch, & Bratic (2013), the lack of chemotherapy agents generates a enormous predicament as oncology patients undergoing treatment cannot be switched to another chemotherapy drug without consequences. If there were a acceptable replacement as evident by previous randomized clinical trials, then equal dosing would exist. 99.5% of hospitals experience pharmaceutical drug shortages as stated by the American Hospital Association. Unpredictable access to reliable substitutes not only puts the patient’s life at risk but also puts a weight on caregivers and healthcare providers. In fact,

So many different types. In the article titled “Cancer Tutor” it says, “With the 122 different types of cancer people all around the world are affected by this.” Men, women, and children are all able to get cancer. This allows cancer to be a lot more common. One of the most common types of cancer is breast cancer. Men or women can have this. Unlike breast cancer some of the more common types of cancer can be caused by humans actions, such as smoking. Smoking can cause lung cancer, which is very typical. Cancer can be found in almost any part of your body, and needs to be checked on every once and awhile.

Cancer patients will now be able to rely on their physician’s decisions to implement treatment

It is fair to mention that talking about cancer burden and difficulties along with ways to conquer it does not make sense without provision of well-organized cancer preventive and diagnostic services. People who are more concerned about cancer (high risk group) due to the experience of family loss owing to cancer or exposure to definitive cancer risk factors may need to get trustable cancer related counseling and guidance, participate in screening/early diagnosis programs and get regular checkups. We, for the first time in Iran, established a center for cancer prevention and early diagnosis to fulfill these demands. In this article the prevention and early detection planning module would

Inadequate and inconsistent drug supply has altered clinical care. Depending on pharmaceutical availability, patients may not be treated based on evidence-based practice, which has affected patient care (2013). Because of these shortages in chemotherapy drugs, patients would have to be told about changes to their treatment regimen. These changes could have the potential to be less effective or have more side effects and this could have a very negative outcome on both patient care and disease

Adverse events are undesirable and usually have harmful outcomes. The event may or may not be related to the treatment, and is not the same as a side effect or an adverse reactionas it is not always clear whether the drug has caused the events or not .

The trend in the management of cancer nowadays is through a multidisciplinary or team approach. It is a team effort involving several disciplines in oncology, medical, paramedical and allied professionals who are necessary in the management of cancer patient. The clinicians convene to review referred cancer patients; formulate and recommends in consensus the best appropriate management using an evidence-based treatment plan to improve patient survival and quality of life. Further more, multidisciplinary conferences provides an avenue of continuing medical education, collaboration for medical staff and health professionals, maintaining a cancer registry, acting as a quality improvement forum, maintaining a commitment

Hello, my name is Sophie Rees and I am here to talk to you all about the charity I work and support for, The Cancer Council. The Cancer Council is one of Australia’s largest independent funders of Cancer Research. Over $70.5 million dollars of research grants totalled in 2015 and this was a major help to us as an organisation. Our organisation straight up funded a huge $48.1 million dollars with also an addition of $22.4 million, which was used for our research funding partners. We provide early prevention and detection programs which are great ways to help people reduce and quit smoking, participate in some physical activity which can reduce any risks of cancer and lastly, to protect themselves from the sun. The Cancer Council manage and have

When a patient/volunteer being administered a drug under clinical trials or outside trials in case of a treatment regimen, undergoes an adverse event to his/her health it is considered to be an adverse event (AE) and is reported and documented. Adverse drug reaction (ADR) is a sub-type of AE. ADR is reported when the patient expresses an unwanted reaction to the administering of a trial drug.